All Stories

  1. Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis – a case report

    Article • BMC Neurology, October 2016, Springer Science + Business Media

    Egil Røsjø

  2. Vitamin D and EBV in RRMS

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Egil Røsjø

  3. Vitamin D and inflammation in RRMS

    Article • Deutsche Zeitschrift für Nervenheilkunde, October 2015, Springer Science + Business Media

    Egil Røsjø

  4. Vitamin D and IFN-beta in RRMS

    Article • Journal of Neuroimmunology, March 2015, Elsevier

    Professor Kjell-Morten Myhr, Egil Røsjø

  5. Vitamin A, D and E and inflammation in RRMS

    Article • Journal of Neuroimmunology, June 2014, Elsevier

    Professor Øivind Torkildsen, Professor Kjell-Morten Myhr, Egil Røsjø

  6. Primary Antitumor Immune Response Mediated by CD4+ T Cells

    Article • Immunity, March 2005, Elsevier

    Egil Røsjø, Dr Alexandre Corthay